# Pulmonx Corporation (LUNG): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Pulmonx Corporation (LUNG) is 37/100, ranked against 24,000+ stocks in 35 markets (Quality 33, Value 36, Momentum 59, each scored against its sector).

- StockRank: 37/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 33, Value 36, Momentum 59: each a 0-100 percentile within Healthcare.
- Position: #16,819 overall, #1,441 in Healthcare.
- Listing: United States, NMS; Healthcare / Medical Devices.
- Last close: 1.95 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 321K.

Source: https://moatmap.ai/stock/LUNG
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker